Bayer AG (BAYN) Given a €102.00 Price Target at Kepler Capital Markets

Kepler Capital Markets set a €102.00 ($121.43) price objective on Bayer AG (FRA:BAYN) in a research note issued to investors on Monday, August 28th. The brokerage currently has a neutral rating on the healthcare company’s stock.

A number of other analysts also recently issued reports on the company. Commerzbank Ag set a €124.00 ($147.62) price objective on Bayer AG and gave the stock a buy rating in a research note on Monday, August 28th. UBS AG set a €125.00 ($148.81) price objective on Bayer AG and gave the stock a buy rating in a research note on Wednesday, August 23rd. Independent Research GmbH set a €120.00 ($142.86) price objective on Bayer AG and gave the stock a neutral rating in a research note on Wednesday, August 23rd. Warburg Research set a €121.00 ($144.05) price objective on Bayer AG and gave the stock a buy rating in a research note on Wednesday, August 23rd. Finally, Jefferies Group LLC set a €137.00 ($163.10) price objective on Bayer AG and gave the stock a buy rating in a research note on Wednesday, August 23rd. Nine analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and an average target price of €119.55 ($142.32).

Shares of Bayer AG (BAYN) traded down 1.256% during mid-day trading on Monday, reaching €110.396. The company’s stock had a trading volume of 154,877 shares. The company’s 50-day moving average price is €107.97 and its 200-day moving average price is €111.21. Bayer AG has a 12-month low of €85.72 and a 12-month high of €123.83. The stock has a market capitalization of €96.28 billion and a P/E ratio of 19.096.

TRADEMARK VIOLATION WARNING: “Bayer AG (BAYN) Given a €102.00 Price Target at Kepler Capital Markets” was first reported by BBNS and is the sole property of of BBNS. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://baseballnewssource.com/markets/kepler-capital-markets-analysts-give-bayer-ag-bayn-a-102-00-price-target/1565500.html.

About Bayer AG

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with our FREE daily email newsletter.

 


Latest News

Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster


Leave a Reply

 
© 2006-2017 BBNS.